Induction of a E b 7 expression on T cells by transforming growth factor (TGF)-b is thought to be important for intestinal intraepithelial T lymphocyte (IEL) entry into the epithelial compartment. However, there has been no in vivo evidence that up-regulation of a E b 7 expression on T cells by TGF-b is critical for the selective localization of intestinal IEL in the epithelial area. We have recently established transgenic mice expressing Smad7 under the control of a distal lck promoter where TGF-b/Smad signaling is speci®cally blocked in mature T cells. Here we showed that TGF-bmediated up-regulation of a E b 7 was impaired on T cells isolated from the Smad7 transgenic mice associated with reduced numbers of intestinal IEL when compared with that in wild-type littermates. These results indicated that failure to induce a E b 7 on T cells by TGF-b resulted in reduced numbers of intestinal IEL, suggesting the importance of a E b 7 expression by TGF-b in selective localization of intestinal IEL.
Introduction
Intestinal intraepithelial T lymphocytes (IEL) represent one of the largest lymphoid populations in the body and are suggested to play an important role in mucosal immunity (1) . Intestinal IEL show a characteristic surface pro®le which differs from T lymphocytes found in the lamina propria (LPL) and peripheral blood (PBL). In particular, >90% of intestinal IEL express high levels of the integrin a E b 7 (2) . In culture, the surface pro®le of IEL changes and resembles that of PBL. Transforming growth factor (TGF)-b restores the unique integrin pro®le of IEL by up-regulation of a E b 7 and is able to do the same on PBL (3, 4) .
The regulation of a E b 7 expression by TGF-b is thought to be important for selective localization or retention of intestinal IEL in the intestinal epithelium (5±7). It has been postulated based on in vitro studies that lymphocytes entering the gastrointestinal tract from the peripheral blood do so via an interaction of a 4 b 7 on their surface with the mucosal-associated cell adhesion molecule (MadCam) on endothelial cells. Subsequent to migration, the a 4 subunit is down-regulated and a E is upregulated by TGF-b in the microenvironment of the intestine. The a E b 7 integrin is suggested to interact with E-cadherin on the enterocyte surface, thereby mediating selective localization or retention of IEL in the epithelium. However, it remains obscure whether regulation of a E b 7 expression on T cells by TGF-b is really critical for selective localization or retention of intestinal IEL in vivo.
TGF-b is a multifunctional cytokine which has diverse effects on a variety of cell types (8) . TGF-b transduces signals from the receptors to the nucleus through the Smad family of proteins (9) . We have recently established transgenic mice expressing Smad7, an intracellular antagonist of TGF-b/Smad signaling (10) , under the control of a distal lck promoter that directed high expression in peripheral T cells (11) . Therefore, we were able to block the TGF-b/Smad signaling pathway speci®cally in mature T cells. Peripheral T cells in the transgenic mice showed high expression of Smad7, which resulted in blockade of the Smad signaling pathway and resistance to TGF-b action (12) . The development of their immune system appeared to be normal and the mice survived into adulthood without any speci®c phenotype (12) .
By using the Smad7 transgenic mice, we determined whether regulation of a E b 7 on T cells by TGF-b was critical for selective localization or retention of intestinal IEL in vivo. We found that TGF-b-mediated up-regulation of a E b 7 was im-paired on T cells from Smad7 transgenic mice and that the number of intestinal IEL was reduced in the transgenic mice. These results suggested that regulation of a E b 7 expression on T cells by TGF-b was involved in localization or retention of intestinal IEL.
Methods

Mice
Transgenic mice expressing Smad7 under control of a distal lck promoter were generated as previously described (12) . Transgene positive founders were backcrossed to B6 mice to establish lines. All experiments used 8-to 10-week-old transgenic mice or the wild-type littermates, weighing 18±23 g, which were matched with sex.
Puri®cation of T cells
Mouse CD4 T cells were puri®ed from splenocytes harvested from the transgenic or wild-type mice by magnetic cell sorting using MACS anti-CD4 microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany) following the manufacturer's recommendation. The purity of mouse CD4 T cells was con®rmed by FACScan (Becton Dickinson, San Jose, CA) and was consistently >99%.
Stimulation of T cells
Puri®ed mouse CD4 T cells (1 Q 10 6 cells/ml) were stimulated with plate-bound anti-CD3 antibody (2C11) (10 mg/ml) (PharMingen, San Diego, CA) in the presence or absence of recombinant human TGF-b1 (10 ng/ml) (R & D, Minneapolis, MN) and were cultured for 3 days in RPMI 1640 with 10% heatinactivated FCS (Gibco, Grand Island, NY) in a humidi®ed 5% CO 2 at 37°C and followed by FACS analysis.
Flow cytometry
Mouse CD4 T cells suspended in PBS containing 0.1% NaN 3 and 1% FCS were incubated on ice with FITC-labeled antia E b 7 (CD103) (2E7), phycoerythrin-labeled anti-CD4, anti-LFA-1, anti-ICAM-1, anti-VLA-4, anti-a 4 b 7 and anti-CD62L antibody (MEL14) (PharMingen). After washing, the cells were analyzed on a FACScan¯ow cytometer (Becton Dickinson) using CellQuest software (Becton Dickinson).
Immuno¯uorescence study
After removal of the small intestine, the samples were embedded in OCT compound and snap frozen in liquid nitrogen. Cryostat sections (4±8 mm thick) were blocked for 5 min with cold acetone and dried for 10 min. After washing the sections twice with PBS, they were incubated for 60 min at room temperature with FITC-labeled anti-CD3 antibody (C2C12), anti-a E b 7 antibody (2E7), anti-ab TCR antibody and anti-gd TCR antibody (PharMingen). For analysis of intestinal IEL number, the average number of cells stained with anti-CD3 antibody/100 villous epithelial cells in at least ®ve randomly selected high power (Q40) ®elds of the proximal jujunal tissue sections was determined with microscopic evaluation as previously described (13) . For analysis of LPL number, a cell was counted as a LPL when it did not overlap the basement membrane and was contained within villi rather than crypts as previously described (13) . The expression of Flag-tagged Smad7 transgene in intestinal IEL in Smad7 transgenic mice was assessed with immunohistochemical staining with optimally diluted biotinylated rabbit polyclonal anti-Flag antibody (Stratagene, La Jolla, CA) as previously described (14) .
Isolation of IEL and LPL
IEL and LPL were isolated from Smad7 transgenic mice and the wild-type littermates by modi®ed procedures as described previously (15) . Brie¯y, each intestinal sample was removed and¯ushed with Ca 2+ /Mg 2+ -free HBSS, and all Peyer's patches were removed. The intestines were then opened longitudinally and cut laterally into small pieces. Each segment was incubated in Ca 2+ /Mg 2+ -free HBSS containing 0.1 mM EDTA and stirred for 30 min twice to remove epithelial cells. Cell suspensions were ®ltered through nylon mesh and then centrifuged. The cell pellet, consisting of IEL and epithelial cells, was suspended in RPMI1640 medium with 10% FCS. The remaining fragments were then transferred tō asks containing RPMI 1640 with 90 U/ml of collagenase and stirred gently for 60 min in a 37°C water bath. Cell suspensions, containing LPL, were ®ltered through nylon mesh and then centrifuged. IEL and LPL were puri®ed using a 45±70% discontinuous Percoll gradient. After the isolation, the number of viable IEL and LPL was counted by Trypan blue dye exclusion. The isolated IEL from Smad7 transgenic mice or the wild-type littermates were subjected to FACscan using anti-CD3, CD4, CD8, a E b 7 , abTCR and gdTCR antibodies as described earlier.
Induction of oral tolerance
Transgenic mice or wild-type littermates (8 weeks old) were fed with 1 mg of ovalbumin (OVA) (Sigma, St Louis, MO) dissolved in 0.2 ml of PBS or PBS alone 3 times every 24 h by gastric intubation with an 18-gauge stainless steel animal feeding needle. Two weeks after the ®nal feeding, the mice were immunized i.p. twice at 2-week intervals with 1 mg of OVA in 4 mg of aluminum hydroxide.
Proliferation assay
Proliferation assay was performed as previously described (12) .
The spleen was removed from the mice 10 days after the second immunization of OVA and a single-cell suspension of spleen cells was prepared. Splenocytes were then cultured in triplicate in the absence or presence of OVA (100 mg/ml) in a 96-well microtiter plate (2 Q 10 5 cells/well) at 37°C in 5% CO 2 for 72 h and 1 mCi of [ 3 H]thymidine (Amersham, Little Chalfont, UK) was added to the culture for the last 12 h. Thymidine incorporation was assessed by harvesting cells with a PHD cell harvester (Cambridge Technologies, Cambridge, MA).
Data analysis
Data are summarized as mean T SD. The statistical analysis of the results was performed by the amount of variance using Fisher's least signi®cant difference test for multiple comparisons. P < 0.05 was considered to be signi®cant.
Results
Induction of a E b 7 expression by TGF-b is abrogated on splenic T cells from Smad7 transgenic mice Induction of a E b 7 expression by TGF-b is thought to be important for selective localization or retention of intestinal IEL in the intestinal epithelium (6) . However, it remains obscure whether up-regulation of a E b 7 expression on T cells by TGF-b is critical for selective localization or retention of intestinal IEL in vivo. We hypothesized that T cells from the transgenic mice expressing Smad7 under control of a distal lck promoter (T cell-speci®c promoter) should be resistant to TGF-b action and up-regulation of a E b 7 by TGF-b might be impaired. If this was the case, we thought that we could determine whether regulation of a E b 7 expression on T cells by TGF-b was critical for selective localization or retention of intestinal IEL in vivo by examining the number of intestinal IEL in the transgenic mice.
As shown in Fig. 1(A) , up-regulation of a E b 7 by TGF-b was impaired on T cells isolated from Smad7 transgenic mice. Puri®ed CD4 + T cells from Smad7 transgenic mice and the wild-type littermates were stimulated with plate-bound anti-CD3 antibody in the absence or presence of recombinant TGF-b1 (10 ng/ml). Three days after the culture, a E b 7 expression on CD4 + T cells was evaluated by FACScan. TGF-b upregulated a E b 7 expression on splenic T cells obtained from wild-type mice as previously described (4), but not from Smad7 transgenic mice.
Additional FACS analyses were performed to determine whether the expression levels of other adhesion molecules were altered on T cells from Smad7 transgenic mice.
As shown in Fig. 1(B) , basal expression levels of LFA-1, VLA-4, ICAM-1 and a E b 7 on splenic T cells were not signi®-cantly different between the transgenic mice and the wild-type littermates. We also found that TGF-b did not signi®cantly alter the basal expression levels of LFA-1, VLA-4 and ICAM-1 on splenic T cells (data not shown). a E b 7 expression was slightly enhanced by TGF-b on splenic T cells from wild-type mice, but not from Smad7 transgenic mice (data not shown). These ®ndings indicated that regulation of a E b 7 expression by TGF-b was abrogated on splenic T cells obtained from Smad7 transgenic mice, probably due to the blockade of TGF-b/ Smad signaling pathway by overexpression of Smad7 in T cells.
The number of intestinal IEL is reduced in Smad7 transgenic mice
Based on the ®ndings that up-regulation of a E b 7 expression by TGF-b was completely abrogated on splenic T cells from Smad7 transgenic mice in vitro, we next examined the number of intestinal IEL in Smad7 transgenic mice and the wild-type littermates by immuno¯uorescence with anti-CD3 antibody.
We found that the number of CD3 + T cells located in the epithelial area of proximal jujunal tissue was reduced by 46% in Smad7 transgenic mice when compared with the wild-type littermates ( Fig. 2A and B) . Staining with anti-a E b 7 antibody showed that the number of a E b 7 + cells in intestinal epithelium was reduced in Smad7 transgenic mice, although there were some signi®cant a E b 7 + cells present in the transgenic mice ( Fig. 2A and B) . In addition, the number of ab + and gd + T cells in the intestinal epithelium was equally reduced in Smad7 transgenic mice ( Fig. 2A and C) . These ®ndings indicated the number of intestinal IEL was reduced in the transgenic mice when compared with the wild-type littermates, and intestinal localization of both subsets of ab and gd IEL were equally affected in Smad7 transgenic mice.
To further con®rm the immuno¯uorescence data, we examined the number of intestinal IEL in Smad7 transgenic mice and the wild-type littermates by carrying out isolation of IEL from the transgenic mice. The number of IEL, but not LPL, isolated from the intestine of Smad7 transgenic mice was signi®cantly reduced when compared with the wild-type littermates (Fig. 3A) . FACS analyses of isolated IEL showed that proportions of subsets of CD4, CD8, and ab and gd IEL in Smad7 transgenic mice did not appear to be different from those in the wild-type littermates (Fig. 3B) . We also found that most IEL isolated from the wild-type mice were a E b 7 + cells, whereas about half of IEL isolated from the transgenic mice were a E b 7 + (Fig. 3B) . These ®ndings were consistent with the earlier results obtained by immuno¯uorescence study.
In addition, expression of Smad7 transgene in Smad7 transgenic mice, but not in the wild-type littermates, was con®rmed by immunohistochemical staining with anti-Flag antibody (Fig. 4) , because we used a plasmid construct expressing Flag-tagged mouse Smad7 (10) under the control of a distal lck promoter for generation of the transgenic mice (12) .
Oral tolerance is induced in Smad7 transgenic mice
Subsets of intestinal IEL are suggested to be involved in induction of oral tolerance (16) . Since we found that the number of intestinal IEL was reduced in both ab and gd subsets of IEL in Smad7 transgenic mice, we determined whether oral tolerance was induced in Smad7 transgenic mice to the same degree as that seen in the wild-type littermates. As shown in Fig. 5 , in vitro OVA-induced T cell proliferation was signi®cantly decreased in sensitized wildtype mice after oral administration of OVA. Signi®cant inhibition of T cell proliferation was also observed after oral administration of OVA in sensitized Smad7 transgenic mice (Fig. 5 ). There was little T cell proliferation in the absence of OVA in sensitized wild-type and Smad7 transgenic mice (data not shown). Interestingly, OVA-induced T cell proliferation was~3 times higher in sensitized Smad7 transgenic mice than that in sensitized wild-type mice, suggesting that endogenous TGF-b might be involved in the suppression of antigen-induced T cell proliferation. These ®ndings indicated that oral tolerance was inducible in Smad7 transgenic mice to the same extent as that observed in wild-type mice. Proximal jejunal tissue sections prepared were stained with FITC-labeled anti-ab or gd TCR antibody (PharMingen) and the number of stained cells/100 villus epithelial cells was determined by microscopic evaluation as described above. Data are mean T SD as described in (B). *P < 0.05.
Discussion
In this study, we showed that TGF-b-mediated up-regulation of a E b 7 was impaired on T cells isolated from Smad7 transgenic mice and that the number of intestinal IEL was reduced in the transgenic mice by 46% when compared with the wild-type littermates (Figs 1±3). These results suggested that regulation of a E b 7 expression on T cells by TGF-b was partially involved in selective localization or retention of intestinal IEL.
We have previously shown that the transgenic mice expressing Smad7 selectively in mature T cells survive into adulthood without any spontaneous phenotype (12) and CD62L in the transgenic mice were not different from the wild-type littermates (Fig. 1B and data not shown) . We thus reasoned that usage of the Smad7 transgenic mice would be appropriate to analyze homeostasis of the mucosal immune system in the absence of experimentally induced infection or in¯ammation.
We found that up-regulation of a E b 7 by TGF-b was completely impaired on T cells isolated from Smad7 transgenic mice in vitro (Fig. 1A) . However, the reduction of CD3 + T cells in the intestinal epithelium was partial and signi®cant numbers of CD3 + T cells were still present in the intestinal epithelium in Smad7 transgenic mice (Figs 2 and 3) . Recently, Schon et al. reported that the number of intestinal IEL was reduced in a E (CD104)-de®cient mice (13) . Consistent with our results, they found that the number of intestinal IEL was diminished, but not completely lost, and signi®cant numbers of intestinal IEL were present in a E -de®cient mice. Some studies suggested that a E b 7 was not essential for the constitution of IEL (4, 17) and b 2 integrin may be also involved in the localization of IEL (18) . Taken together with our current ®ndings, not only the regulation of a E b 7 by TGF-b but also other molecular regulation mechanisms including b 2 integrins could be involved by which intestinal IEL localize in the epithelial area in vivo.
Interestingly, there were some a E b 7 + cells present in the epithelium of Smad7 transgenic mice (Figs 2 and 3) . These ®ndings suggested that there was redundancy in the regulation of a E b 7 expression on T cells and stimuli other than TGF-b might be involved in the regulation of a E b 7 in vivo. Alternatively, it is possible that we did not achieve complete blockade of the Smad signaling pathway in vivo and`leakage' of Smad7 occurred in Smad7 transgenic mice, which might lead to a E b 7 expression on some intestinal IEL in Smad7 transgenic mice. This issue should be investigated in future studies.
Subsets of intestinal IEL are suggested to play a role in induction of oral tolerance (16) . Although we found that the number of intestinal IEL was reduced in Smad7 transgenic mice, oral tolerance was inducible in Smad7 transgenic mice to the same degree as that seen in the wild-type littermates. These ®ndings indicated that reduced numbers of intestinal IEL in Smad7 transgenic mice did not affect induction of oral tolerance. It is possible that residual intestinal IEL present in Smad7 transgenic mice are suf®cient for induction of oral tolerance. Since intestinal IEL are suggested to have various functions (19) , we cannot exclude the possibility that other in vivo functions of intestinal IEL are affected in Smad7 transgenic mice.
In summary, we showed that TGF-b-mediated up-regulation of a E b 7 was impaired on T cells isolated from Smad7 transgenic mice and that the number of intestinal IEL was reduced in the transgenic mice when compared with the wildtype littermates. We have thus provided evidence that regulation of a E b 7 expression by TGF-b on T cells is involved in selective localization or retention of intestinal IEL in vivo. These ®ndings demonstrate an important role of a E b 7 regulation by TGF-b in modulating the homeostasis of T lymphocyte number in the intestine. 
